Special Issue
Signature of normal and cancer cells: molecular targets for cancer therapy
Submission Deadline: 31 December 2014
Articles: 9
Special Issue Editor
Guest Editor
Subrata Haldar
Staff Scientist, Research, Pharmacology, Ireland Cancer Center, 2500 MetroHealth Drive, Cleveland, OH 44109, USA
Expertise: 60 publications, 4 grants, Editor of Frontiers in Bioscience
Manuscript Submission Information

Manuscripts should be submitted online at https://jour.ipublishment.com/bri by registering and logging into this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a double-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page.

Please visit the Instructions for Authors page before submitting a manuscript. Submitted papers should be well formatted and written in clear, concise English and should contain all essential data in order to make the presentation clear and the results of the study replicable. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see

here.

Keywords
Cancer, Molecular Biology, Technology, Therapeutics
Share This Special Issue
Published Papers (9 papers)
Open Access
Article
Embelin suppresses pancreatic cancer growth by modulating tumor immune microenvironment
Justine L. Marsh, Chris P. Jackman, Su-Ni Tang, Sharmila Shankar, Rakesh K. Srivastava
Frontiers in Bioscience-Landmark Volume 19 Issue 1, pp.113-125
Managing Editor: Subrata Haldar
DOI: 10.2741/4198 Published: 01 January 2014
Open Access
Article
Signature of mitochondria of steroidal hormones-dependent normal and cancer cells: potential molecular targets for cancer therapy
Deodutta Roy, Quentin Felty, Satya Narayan, Prasanna Jayakar
Frontiers in Bioscience-Landmark Volume 12 Issue 1, pp.154-173
Managing Editor: Subrata Haldar
DOI: 10.2741/2056 Published: 01 January 2007
Open Access
Article
Function and dysfunction of the human oncoprotein MDM2
Swati Palit Deb
Frontiers in Bioscience-Landmark Volume 7 Issue 4, pp.235-243
Managing Editor: Subrata Haldar
DOI: 10.2741/A723 Published: 01 January 2002
Open Access
Article
Tumor antigen targets and tumor immunotherapy
R Allan Mufson
Frontiers in Bioscience-Landmark Volume 11 Issue 1, pp.337-343
Managing Editor: Subrata Haldar
DOI: 10.2741/1801 Published: 01 January 2006
Open Access
Article
Chromosomal deletions in bladder cancer: shutting down pathways
Reimar Abraham, Francesco Pagano, Leonard G Gomella, Raffaele Baffa
Frontiers in Bioscience-Landmark Volume 12 Issue 3, pp.826-838
Managing Editor: Subrata Haldar
DOI: 10.2741/2105 Published: 01 January 2007
Open Access
Article
Estrogen receptor regulation of quinone reductase in breast cancer: implications for estrogen-induced breast tumor growth and therapeutic uses of tamoxifen
Monica M Montano, Nicole R Bianco, Huayun Deng, Bryan M Wittmann, Laura C Chaplin, Benita S Katzenellenbogen
Frontiers in Bioscience-Landmark Volume 10 Issue 2, pp.1440-1461
Managing Editor: Subrata Haldar
DOI: 10.2741/1630 Published: 01 May 2005
Open Access
Article
Posttranslational modifications of Bcl2 family members--a potential therapeutic target for human malignancy
Aruna Basu, Garrett DuBois, Subrata Haldar
Frontiers in Bioscience-Landmark Volume 11 Issue 2, pp.1508-1521
Managing Editor: Subrata Haldar
DOI: 10.2741/1900 Published: 01 May 2006
Open Access
Article
APO2 ligand/tumor necrosis factor-related apoptosis-inducing ligand in prostate cancer therapy
Octavian Bucur, Subrata Ray, Maria Cristina Bucur, Alexandru Almasan
Frontiers in Bioscience-Landmark Volume 11 Issue 2, pp.1549-1568
Managing Editor: Subrata Haldar
DOI: 10.2741/1903 Published: 01 May 2006
Open Access
Article
2-Methoxyestradiol mediated signaling network in pancreatic cancer
Aruna Basu, Subrata Haldar
Frontiers in Bioscience-Landmark Volume 14 Issue 6, pp.2170-2180
Managing Editor: Subrata Haldar
DOI: 10.2741/3369 Published: 01 January 2009